Derek H Chu, Abby S Van Voorhees, Misha Rosenbach. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdalimumabAdrenal Cortex Hormones/therapeutic useAdultAlefaceptAnti-Inflammatory Agents/adverse effectsAnti-Inflammatory Agents/therapeutic useAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, Humanized/adverse effectsAntibodies, Monoclonal, Humanized/therapeutic useAntirheumatic Agents/adverse effectsAntirheumatic Agents/therapeutic useArthritis, Rheumatoid/drug therapyCrohn Disease/drug therapyCyclosporine/therapeutic useEtanerceptFemaleHumansImmunoglobulin G/adverse effectsImmunoglobulin G/therapeutic useMethotrexate/therapeutic useMiddle AgedMycophenolic Acid/analogs & derivativesMycophenolic Acid/therapeutic usePUVA TherapyPsoriasis/drug therapyPsoriasis/etiologyReceptors, Tumor Necrosis Factor/therapeutic useRecombinant Fusion Proteins/therapeutic useTreatment OutcomeUstekinumab
Substances: See more » Adrenal Cortex HormonesAnti-Inflammatory AgentsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntirheumatic AgentsImmunoglobulin GReceptors, Tumor Necrosis FactorRecombinant Fusion ProteinsCyclosporineAlefaceptUstekinumabAdalimumabMycophenolic AcidEtanerceptefalizumabMethotrexate
Year: 2011 PMID: 22006150 DOI: 10.1001/archdermatol.2011.275
Source DB: PubMed Journal: Arch Dermatol ISSN: 0003-987X